The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.
Also called NCT02251847
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 400 participants
- Sponsor
- Registry
-
NCT02251847
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02251847. Randomized; double masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2015-07 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Efficacy and Safety of a Combination Therapy of Rosuvastatin and Ezetimibe Versus Monotherapy of Rosuvastatin in Hypercholesterolemia Patients
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Rosuvastatin/Ezetimibe
- Lead sponsor
- IlDong Pharmaceutical Co Ltd
Record details
- Record id
cardio:ct-nct02251847- Content hash
34476c0b7d2cb15b15b59a55a3af6442d599554da945c6f2760c2de71b0246c5